This year’s Festival of Biologics was an inspiring event for AnalysisMode as we joined the Start-up Area in Basel to connect with industry experts, exchange ideas, and present our latest advancements in AI-driven bioprocessing technology. Our team showcased SimCell, an AI-powered platform that combines bioprocess models and digital twins to support innovative process development and optimization.
Our poster presentation sparked dynamic conversations with scientists, researchers, and biopharma leaders on how virtual experimentation through SimCell can reduce traditional wet-lab workloads and streamline the path from early development to scale-up. With SimCell, biomanufacturing teams can analyze complex data sets faster, uncover insights to refine processes, and ultimately bring products to market more efficiently.
Key Highlights from the Festival of Biologics 2024:
- AI in Biologics: Attendees were eager to discuss the transformative role AI is playing in biologics, particularly how it enables rapid, data-driven decision-making in areas that once relied heavily on manual experimentation. We explored how AI in bioprocessing is advancing the field, not by replacing human expertise, but by enhancing it—empowering scientists to achieve more, with greater precision.
- Supporting Innovation: The event provided a unique forum to connect with other start-ups, established companies, and funding experts, all united by a commitment to drive innovation in biologics. From panel discussions to networking sessions, the focus on advancing AI and supporting biotech startups made for a truly collaborative atmosphere.
- Exploring Industry Challenges: Our conversations frequently turned to the challenges of scaling up biologics production. With the rising demand for innovative therapies, we delved into how AI-powered platforms like SimCell can help biomanufacturing teams navigate the complexities of scale-up while ensuring quality and efficiency. The insights gained from these discussions will be invaluable as we continue to refine our solutions to meet industry needs.
We extend our gratitude to everyone who visited our space, shared insights, and explored the possibilities of AI in bioprocessing with us. The future of biopharma is bright, and we’re excited to be at the forefront of this transformation, helping teams around the world optimize their workflows and push the boundaries of what’s possible in bioprocess development.